Method for detecting human papillomavirus mRNA

Details for Australian Patent Application No. 2003201639 (hide)

International Classifications

Event Publications

3 April 2003 Complete Application Filed

Priority application(s): 0200239.2 07.01.02 GB; 0214124.0 19.06.02 GB

4 September 2003 Application Open to Public Inspection

Published as AU-B-2003201639

15 May 2008 Application Accepted

Published as AU-B-2003201639

11 September 2008 Standard Patent Sealed

9 October 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 27 Aug 2008. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000 2003214127 1-[alkyl], 1-[heteroaryl)alkyl] and 1-[aryl)alkyl]-7-(pyrimidin-4-yl)-imadazo[1,2-a] pyrimidin-5(1H)-one derivatives Mitsubishi Pharma Corporation; Sanofi-Aventis The nature of the amendment is as shown in the statement(s) filed 28 Aug 2008. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson

26 February 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Aug 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.